HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-01-15
著者
-
Klimes Jiri
Department Of Pharmaceutical Chemistry And Drug Control Charles University In Prague Faculty Of Phar
-
Klimes Jiri
Department Of Pharmaceutical Chemistry And Drug Control Faculty Of Pharmacy In Hradec Kralove Charle
-
Richardson Des
Iron Metabolism And Chelation Program Department Of Pathology And Bosch Institute University Of Sydn
-
Kalinowski Danuta
Iron Metabolism And Chelation Program Department Of Pathology And Bosch Institute University Of Sydn
-
STARIAT Jan
Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy in Hradec Kralove, Char
-
KOVARIKOVA Petra
Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy in Hradec Kralove, Char
-
LOVEJOY David
Iron Metabolism and Chelation Program, Department of Pathology and Bosch Institute, University of Sy
-
Stariat Jan
Department Of Pharmaceutical Chemistry And Drug Control Faculty Of Pharmacy In Hradec Kralove Charle
-
Lovejoy David
Iron Metabolism And Chelation Program Department Of Pathology And Bosch Institute University Of Sydn
-
Kovarikova Petra
Department Of Pharmaceutical Chemistry And Drug Control Faculty Of Pharmacy In Hradec Kralove Charle
関連論文
- High-performance liquid chromatographic method with UV photodiode-array, fluorescence and mass spectrometric detection for simultaneous determination of galantamine and its phase I metabolites in biological samples
- HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents
- HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study